{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:23:51Z","timestamp":1777598631482,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T00:00:00Z","timestamp":1381795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T00:00:00Z","timestamp":1381795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/tpj.2013.37","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T09:54:13Z","timestamp":1381830853000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson\u2019s disease patients"],"prefix":"10.1038","volume":"14","author":[{"given":"A F","family":"Schumacher-Schuh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Tovo-Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T L","family":"Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Callegari-Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R M","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Hutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"BFtpj201337_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML De Lau","year":"2006","unstructured":"De Lau LML, Breteler MMB . Epidemiology of Parkinson\u2019s disease. Lancet Neurology 2006; 5: 525\u2013535.","journal-title":"Lancet Neurology"},{"key":"BFtpj201337_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","volume":"289","author":"G F\u00e9nelon","year":"2010","unstructured":"F\u00e9nelon G, Alves G . Epidemiology of psychosis in Parkinson\u2019s disease. J Neurol Sci 2010; 289: 12\u201317.","journal-title":"J Neurol Sci"},{"key":"BFtpj201337_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD . Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001; 16: 448\u2013458.","journal-title":"Mov Disord"},{"key":"BFtpj201337_CR4","first-page":"101","volume":"8","author":"JG Nutt","year":"2001","unstructured":"Nutt JG . Motor fluctuations and dyskinesia in Parkinson\u2019s disease. Mov Disord 2001; 8: 101\u2013108.","journal-title":"Mov Disord"},{"key":"BFtpj201337_CR5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1001\/archneur.63.12.1756","volume":"63","author":"RA Hauser","year":"2006","unstructured":"Hauser RA, McDermott MP, Messing S . Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease. Arch Neurol 2006; 63: 1756\u20131760.","journal-title":"Arch Neurol"},{"key":"BFtpj201337_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","volume":"9","author":"P Calabresi","year":"2010","unstructured":"Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B . Levodopa-induced dyskinesias in patients with Parkinson\u2019s disease: filling the bench-to-bedside gap. Lancet Neurol 2010; 9: 1106\u20131117.","journal-title":"Lancet Neurol"},{"key":"BFtpj201337_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archneurol.2010.166","volume":"67","author":"EB Forsaa","year":"2010","unstructured":"Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010; 67: 996\u20131001.","journal-title":"Arch Neurol"},{"key":"BFtpj201337_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tips.2005.06.007","volume":"26","author":"G Linazasoro","year":"2005","unstructured":"Linazasoro G . New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity. Trends Pharmacol Sci 2005; 26: 391\u2013397.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtpj201337_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1471-4159.2002.00869.x","volume":"81","author":"U Thomas","year":"2002","unstructured":"Thomas U . Modulation of synaptic signalling complexes by Homer proteins. J Neurochem 2002; 81: 407\u2013413.","journal-title":"J Neurochem"},{"key":"BFtpj201337_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.neuint.2012.06.014","volume":"61","author":"P Luo","year":"2012","unstructured":"Luo P, Li X, Fei Z, Poon W . Scaffold protein Homer 1: implications for neurological diseases. Neurochem Int 2012; 61: 731\u2013738.","journal-title":"Neurochem Int"},{"key":"BFtpj201337_CR11","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1523\/JNEUROSCI.18-14-05301.1998","volume":"18","author":"JD Berke","year":"1998","unstructured":"Berke JD, Paletzki RF, Aronson GJ, Hyman SE, Gerfen CR . A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 1998; 18: 5301\u20135310.","journal-title":"J Neurosci"},{"key":"BFtpj201337_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.jnen.0000186922.42592.b7","volume":"64","author":"V Sgambato-Faure","year":"2005","unstructured":"Sgambato-Faure V, Buggia V, Gilbert F, L\u00e9vesque D, Benabid A-L, Berger F . Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J Neuropathol Exp Neurol 2005; 64: 936\u2013947.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFtpj201337_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2006.11.011","volume":"1131","author":"H Yamada","year":"2007","unstructured":"Yamada H, Kuroki T, Nakahara T, Hashimoto K, Tsutsumi T, Hirano M et al. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Brain Res 2007; 1131: 88\u201396.","journal-title":"Brain Res"},{"key":"BFtpj201337_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1460-9568.2006.05264.x","volume":"25","author":"J Henning","year":"2007","unstructured":"Henning J, Koczan D, Glass A, Karopka T, Pahnke J, Rolfs A et al. Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. Eur J Neurosci 2007; 25: 239\u2013250.","journal-title":"Eur J Neurosci"},{"key":"BFtpj201337_CR15","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2217\/pgs.12.149","volume":"13","author":"M Rieck","year":"2012","unstructured":"Rieck M, Schumacher-Schuh AF, Altmann V, Francisconi CL, Fagundes PT, Monte TL et al. DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson\u2019s disease patients. Pharmacogenomics 2012; 13: 1701\u20131710.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201337_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1017\/S1461145712001666","volume":"16","author":"AF Schumacher-Schuh","year":"2013","unstructured":"Schumacher-Schuh AF, Francisconi C, Altmann V, Monte TL, Callegari-Jacques SM, Rieder CR et al. Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson\u2019s disease. Int J Neuropsychopharmacol 2013; 16: 1251\u20131258.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtpj201337_CR17","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ . What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study. Neurology 1992; 42: 1142\u20131146.","journal-title":"Neurology"},{"key":"BFtpj201337_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mds.870090112","volume":"9","author":"P Mart\u00ednez-Mart\u00edn","year":"1994","unstructured":"Mart\u00ednez-Mart\u00edn P, Gil-Nagel A, Gracia LM, G\u00f3mez JB, Mart\u00ednez-Sarri\u00e9s J, Bermejo F . Unified Parkinson\u2019s Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994; 9: 76\u201383.","journal-title":"Mov Disord"},{"key":"BFtpj201337_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD . Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427\u2013442.","journal-title":"Neurology"},{"key":"BFtpj201337_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR . \u2018Mini-mental state\u2019. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189\u2013198.","journal-title":"J Psychiatr Res"},{"key":"BFtpj201337_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-022X(92)90014-2","volume":"25","author":"DK Lahiri","year":"1992","unstructured":"Lahiri DK, Bye S, Nurnberger JI, Hodes ME, Crisp M . A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods 1992; 25: 193\u2013205.","journal-title":"J Biochem Biophys Methods"},{"key":"BFtpj201337_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000230689","volume":"59","author":"V De Luca","year":"2009","unstructured":"De Luca V, Annesi G, De Marco EV, De Bartolomeis A, Nicoletti G, Pugliese P et al. HOMER1 promoter analysis in Parkinson\u2019s disease: association study with psychotic symptoms. Neuropsychobiology 2009; 59: 239\u2013245.","journal-title":"Neuropsychobiology"},{"key":"BFtpj201337_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000119108","volume":"66","author":"F Dudbridge","year":"2008","unstructured":"Dudbridge F . Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 89\u201398.","journal-title":"Hum Hered"},{"key":"BFtpj201337_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263\u2013265.","journal-title":"Bioinformatics"},{"key":"BFtpj201337_CR25","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE . Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 2010; 25: 2649\u20132653.","journal-title":"Mov Disord"},{"key":"BFtpj201337_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archneur.62.4.601","volume":"62","author":"M Zappia","year":"2005","unstructured":"Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D et al. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch Neurol 2005; 62: 601\u2013605.","journal-title":"Arch Neurol"},{"key":"BFtpj201337_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archderm.142.6.761","volume":"142","author":"KA Katz","year":"2006","unstructured":"Katz KA . The (relative) risks of using odds ratios. Arch Dermatol 2006; 142: 761\u2013764.","journal-title":"Arch Dermatol"},{"key":"BFtpj201337_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-3-21","volume":"3","author":"AJD Barros","year":"2003","unstructured":"Barros AJD, Hirakata VN . Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21.","journal-title":"BMC Med Res Methodol"},{"key":"BFtpj201337_CR29","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","volume":"57","author":"CG Goetz","year":"2001","unstructured":"Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB . Prospective longitudinal assessment of hallucinations in Parkinson\u2019s disease. Neurology 2001; 57: 2078\u20132082.","journal-title":"Neurology"},{"key":"BFtpj201337_CR30","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","volume":"70","author":"S Holroyd","year":"2001","unstructured":"Holroyd S, Currie L, Wooten GF . Prospective study of hallucinations and delusions in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatr 2001; 70: 734\u2013738.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BFtpj201337_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archneur.56.5.595","volume":"56","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Cummins JL, Laake K . Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999; 56: 595\u2013601.","journal-title":"Arch Neurol"},{"key":"BFtpj201337_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0317167100013974","volume":"39","author":"B Elahi","year":"2012","unstructured":"Elahi B, Phielipp N, Chen R . N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis. Can J Neurol Sci 2012; 39: 465\u2013472.","journal-title":"Can J Neurol Sci"},{"key":"BFtpj201337_CR33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/brain\/awr028","volume":"134","author":"I Ahmed","year":"2011","unstructured":"Ahmed I, Bose SK, Pavese N, Ramlackhansingh A, Turkheimer F, Hotton G et al. Glutamate NMDA receptor dysregulation in Parkinson\u2019s disease with dyskinesias. Brain 2011; 134: 979\u2013986.","journal-title":"Brain"},{"key":"BFtpj201337_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/FPC.0b013e328306c2f2","volume":"18","author":"M Bialecka","year":"2008","unstructured":"Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan E-K, Drozdzik M . The association of functional catechol-O-methyl transferase haplotypes with risk of Parkinson\u2019s disease, levodopa treatment response, and complications. Pharmacogenet Genomics 2008; 18: 815\u2013821.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201337_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/mds.22508","volume":"24","author":"S Paus","year":"2009","unstructured":"Paus S, Gadow F, Knapp M, Klein C, Klockgether T, W\u00fcllner U . Motor complications in patients form the German Competence Network on Parkinson\u2019s disease and the DRD3 Ser9Gly polymorphism. Mov Disord 2009; 24: 1080\u20131084.","journal-title":"Mov Disord"},{"key":"BFtpj201337_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/humu.21159","volume":"31","author":"NPC Santos","year":"2010","unstructured":"Santos NPC, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AKC, Pereira R, Gusm\u00e3o L, Amorim A et al. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat 2010; 31: 184\u2013190.","journal-title":"Hum Mutat"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201337","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:06:23Z","timestamp":1647943583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,15]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFtpj201337"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2013.37","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,15]]},"assertion":[{"value":"17 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}